Otsuka Adopts A New Mindset
Otsuka Pharmaceuticals, the company that developed the blockbuster drug Abilify, has acquired a Canadian psychedelic biotech company, Mindset Pharma, for $59 million (USD).
The all-cash transaction gives Otsuka control over Mindset's preclinical pipeline of psychedelics, which includes a psil...
Dec 09, 2023
127 views
